Presentation

0 Comments

18 December 2016

How to avoid bleeding – 2: The pharmacology

Dr. Jon Byrne

Bleeding Matters: How to avoid bleeding - 2: The pharmacology

Previous | Next
Download

Summary

Dr. Byrne describes pharamaoclogical stratergies to reduce bleeding during PCI.

He explains the roles of:

  • Reduced dose/no heparin
  • Low molecular weight heparin vs. unfractionated heparin
  • Newer synthetic anticoagulants
  • Bivilarudin vs. heparin/GPIIb/IIIa Inhibitors
  • Reduced dose of GPIIb/IIIa inhibitors

Download

Summary

Dr. Byrne describes pharamaoclogical stratergies to reduce bleeding during PCI.

He explains the roles of:

  • Reduced dose/no heparin
  • Low molecular weight heparin vs. unfractionated heparin
  • Newer synthetic anticoagulants
  • Bivilarudin vs. heparin/GPIIb/IIIa Inhibitors
  • Reduced dose of GPIIb/IIIa inhibitors

You have to be a BCIS member to access this content

Either Sign in or register to become a member, today! Join BCIS Sign In